BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10780930)

  • 1. Role of C-peptide in human physiology.
    Wahren J; Ekberg K; Johansson J; Henriksson M; Pramanik A; Johansson BL; Rigler R; Jörnvall H
    Am J Physiol Endocrinol Metab; 2000 May; 278(5):E759-68. PubMed ID: 10780930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular effects of C-peptide--new perspectives on an old peptide.
    Wahren J; Shafqat J; Johansson J; Chibalin A; Ekberg K; Jörnvall H
    Exp Diabesity Res; 2004; 5(1):15-23. PubMed ID: 15198368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide: new findings and therapeutic implications in diabetes.
    Wahren J
    Clin Physiol Funct Imaging; 2004 Jul; 24(4):180-9. PubMed ID: 15233831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ernst-Friedrich-Pfeiffer Memorial Lecture. New aspects of C-peptide physiology.
    Wahren J; Johansson BL
    Horm Metab Res; 1998 Jan; 30(1):A2-5. PubMed ID: 9503042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide makes a comeback.
    Wahren J; Jörnvall H
    Diabetes Metab Res Rev; 2003; 19(5):345-7. PubMed ID: 12951641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide: a new potential in the treatment of diabetic nephropathy.
    Wahren J; Ekberg K; Samnegård B; Johansson BL
    Curr Diab Rep; 2001 Dec; 1(3):261-6. PubMed ID: 12643208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological effects of the connecting peptide].
    Tsimaratos M
    Arch Pediatr; 2005 Apr; 12(4):442-8. PubMed ID: 15808437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does C-peptide have a physiological role?
    Wahren J; Johansson BL; Wallberg-Henriksson H
    Diabetologia; 1994 Sep; 37 Suppl 2():S99-107. PubMed ID: 7821746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects on biological activity of C-peptide in IDDM patients.
    Forst T; Kunt T; Pfützner A; Beyer J; Wahren J
    Exp Clin Endocrinol Diabetes; 1998; 106(4):270-6. PubMed ID: 9792458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-peptide revisited--new physiological effects and therapeutic implications.
    Wahren J; Johansson BL; Wallberg-Henriksson H; Linde B; Fernqvist-Forbes E; Zierath JR
    J Intern Med; 1996 Sep; 240(3):115-24. PubMed ID: 8862120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Peptide effects on renal physiology and diabetes.
    Rebsomen L; Khammar A; Raccah D; Tsimaratos M
    Exp Diabetes Res; 2008; 2008():281536. PubMed ID: 18509500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of C-peptide on glucose utilisation.
    Wilhelm B; Kann P; Pfützner A
    Exp Diabetes Res; 2008; 2008():769483. PubMed ID: 18389076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular signalling by C-peptide.
    Hills CE; Brunskill NJ
    Exp Diabetes Res; 2008; 2008():635158. PubMed ID: 18382618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the potential role of C-peptide in diabetes and osteoporosis.
    Pujia A; Gazzaruso C; Montalcini T
    Endocrine; 2017 Dec; 58(3):408-412. PubMed ID: 28374151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiological effects of C-peptide].
    Tsimaratos M
    Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological effects of proinsulin C-peptide].
    Kimura K
    Seikagaku; 2005 May; 77(5):419-23. PubMed ID: 15952332
    [No Abstract]   [Full Text] [Related]  

  • 18. C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients.
    Johansson BL; Pernow J
    Acta Physiol Scand; 1999 Jan; 165(1):39-44. PubMed ID: 10072095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.